Trial Profile
A Retrospective study to evaluate the efficacy of concurrent capecitabine/radiation therapy in women with stage I-III breast cancer who had received neoadjuvant chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jun 2017
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 05 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 05 Jun 2017 New trial record